Home › Kleincellige longkanker › Maryland › Baltimore
Kleincellige longkanker klinische studies in Baltimore, MD
11 studies voor Kleincellige longkanker zoeken deelnemers op locaties in en rond Baltimore (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RekruterenFase 3
- University of Maryland School of Medicine, Baltimore
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
RekruterenFase 1/2
- United Theranostics, Glen Burnie · 9 mijl verwijderd
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
RekruterenFase 2
- University of Maryland, Baltimore
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RekruterenFase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RekruterenFase 3
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
- John Hopkins School of Medicine, Baltimore
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
RekruterenFase 2
- University of Maryland School of Medicine, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruterenFase 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekruterenFase 1/2
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
RekruterenObservatieonderzoek
- Johns Hopkins University, Baltimore
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
RekruterenFase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
RekruterenFase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Kleincellige longkanker studies in andere steden
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Detroit, MI12 studies
- Chicago, IL12 studies
Andere studies in Baltimore
- Niet-kleincellige longkanker60 studies
- Borstkanker47 studies
- Prostaatkanker43 studies
- Longkanker40 studies
- Kanker (alle vormen)37 studies
- Colorectale kanker31 studies
- Aldermeesklierkanker31 studies
- Metastatische kanker28 studies
- Obesitas25 studies
- Hartfalen24 studies
- Blasenkanker24 studies
- Beroerte22 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.